ivica matak
ivica matak
Znanstveni suradnik, Medicinski fakultet Sveučilišta u Zagrebu
Potvrđena adresa e-pošte na mef.hr
Naslov
Citirano
Citirano
Godina
Behavioral and immunohistochemical evidence for central antinociceptive activity of botulinum toxin A
I Matak, L Bach-Rojecky, B Filipović, Z Lacković
Neuroscience 186, 201-207, 2011
1742011
Botulinum toxin A, brain and pain
I Matak, Z Lacković
Progress in neurobiology 119, 39-59, 2014
1382014
Botulinum toxin’s axonal transport from periphery to the spinal cord
I Matak, P Riederer, Z Lacković
Neurochemistry international 61 (2), 236-239, 2012
1052012
Central action of peripherally applied botulinum toxin type A on pain and dural protein extravasation in rat model of trigeminal neuropathy
B Filipović, I Matak, L Bach-Rojecky, Z Lacković
PLoS one 7 (1), e29803, 2012
942012
Mechanisms of botulinum toxin type A action on pain
I Matak, K Bölcskei, L Bach-Rojecky, Z Helyes
Toxins 11 (8), 459, 2019
542019
Activity of botulinum toxin type A in cranial dura: implications for treatment of migraine and other headaches
Z Lacković, B Filipović, I Matak, Z Helyes
British journal of pharmacology 173 (2), 279-291, 2016
512016
Botulinum toxin type A selectivity for certain types of pain is associated with capsaicin-sensitive neurons
I Matak, O Rossetto, Z Lacković
PAIN® 155 (8), 1516-1526, 2014
482014
Involvement of μ-opioid receptors in antinociceptive action of botulinum toxin type A
V Drinovac, L Bach-Rojecky, I Matak, Z Lacković
Neuropharmacology 70, 331-337, 2013
462013
Botulinum neurotoxin type A: Actions beyond SNAP-25?
I Matak, Z Lacković
Toxicology 335, 79-84, 2015
452015
Dural neurogenic inflammation induced by neuropathic pain is specific to cranial region
B Filipović, I Matak, Z Lacković
Journal of Neural Transmission 121 (5), 555-563, 2014
232014
Transynaptic action of botulinum neurotoxin type A at central cholinergic boutons
M Caleo, M Spinelli, F Colosimo, I Matak, O Rossetto, Z Lackovic, ...
Journal of Neuroscience 38 (48), 10329-10337, 2018
212018
Involvement of substance P in the antinociceptive effect of botulinum toxin type A: Evidence from knockout mice
I Matak, V Tékus, K Bölcskei, Z Lacković, Z Helyes
Neuroscience 358, 137-145, 2017
192017
Effects of botulinum toxin type A facial injection on monoamines and their metabolites in sensory, limbic and motor brain regions in rats
S Ibragić, I Matak, A Dračić, A Smajlović, M Muminović, F Proft, E Sofić, ...
Neuroscience letters 617, 213-217, 2016
142016
Comparison of analgesic effects of single versus repeated injection of botulinum toxin in orofacial formalin test in rats
I Matak, I Stracenski, Z Lacković
Journal of Neural Transmission 120 (1), 141-144, 2013
92013
Evidence for central antispastic effect of botulinum toxin type A
I Matak
British journal of pharmacology 177 (1), 65-76, 2020
82020
Botulinum toxin type A in motor nervous system: unexplained observations and new challenges
I Matak, Z Lacković, M Relja
Journal of Neural Transmission 123 (12), 1415-1421, 2016
82016
Association of intranasal and neurogenic dural inflammation in experimental acute rhinosinusitis
L Lovrenčić, I Matak, Z Lacković
Frontiers in Pharmacology 11, 2020
12020
Axonal transport of botulinum toxin A from periphery to CNS in sensory and motor nerves
I Matak, L Bach-Rojecky, B Filipović, P Riederer, Z Lacković
BMC Pharmacology and Toxicology 13 (1), 1-1, 2012
12012
LONG-TERM EFFECTS OF BOTULINUM NEUROTOXIN TYPE A ON EXPERIMENTAL MUSCLE HYPERTONIA
I Matak, P Sostaric
TOXICON 190, S49-S49, 2021
2021
A hacked kitchen scale-based system for quantification of grip strength in rodents
J Homolak, D Virag, I Kodvanj, I Matak, AB Perhoc, A Knezovic, JO Barilar, ...
bioRxiv, 2020.07. 23.217737, 2021
2021
Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.
Članci 1–20